Fennec Pharmaceuticals

Ticker FENC

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

1-10 Employees
Based in Research Triangle Park, North Carolina

Fennec Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced ototoxicity in pediatric patients. STS has received Orphan Drug Designation in the US in this setting.

Visit website

Social Media Links